TITLE:
Vaccine Therapy for Patients With Stage IV Melanoma

CONDITION:
Malignant Melanoma

INTERVENTION:
CancerVax vaccine (CANVAXIN)

SUMMARY:

      This is a Phase III study in patients with melanoma that has spread to the lymph nodes
      and/or a distant organ, and who have had all of their cancer surgically removed. The purpose
      of this study is to evaluate the ability of the CancerVax vaccine to prevent or slow the
      recurrence of melanoma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        -  Must have Stage IV melanoma

          -  Must have had all clinically-detectable disease surgically removed

          -  Cannot be taking any medications, or undergoing any therapies which compromise the
             functioning of your immune system (ie. Some corticosteroids, and certain types of
             radiation therapy)

          -  Cannot have HIV or Hepatitis A, B, or C
      
